Loading...

Purified anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_Purified_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and purified N418 (top) or purified Armenian hamster IgG isotype control (bottom), followed by anti-Armenian hamster IgG FITC
  • N418_A_Purified_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and purified N418 (top) or purified Armenian hamster IgG isotype control (bottom), followed by anti-Armenian hamster IgG FITC
  • N418_B_Purified_Neg_071006.jpg
Compare all formats
Cat # Size Price Quantity Check Availability Save
117301 50 µg $36
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117302 500 µg $141
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
CyTOF® - Verified
IP, IHC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  2. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  3. Owen KL, et al. 2020. EMBO Rep. 21:e50162. PubMed
  4. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  5. Paterson MJ, et al. 2020. PLoS Pathog. 16:e1008733. PubMed
  6. Bruce DW, et al. 2021. Blood Adv. 5:4578. PubMed
  7. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  8. Martinez LE, et al. 2020. J Virol. 94:00:00. PubMed
  9. Dallari S, et al. 2017. Nat Commun. 8:14830. PubMed
  10. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  11. Bajaña S, et al. 2021. Front Immunol. 11:577718. PubMed
  12. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  13. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  14. Mendes A, et al. 2021. Life Sci Alliance. 4:00. PubMed
  15. Fahlén-Yrlid L, et al. 2009. J Immunol. 183:5032. PubMed
  16. Osterholzer J, et al. 2009. J Immunol. 183:8044. PubMed
  17. Sun L, et al. 2020. Nat Commun. 2.229166667. PubMed
  18. Trittel S, et al. 2019. Sci Rep. 9:16362. PubMed
  19. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  20. Bhatt K, et al. 2018. mSphere. 3:e00352. PubMed
  21. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  22. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  23. Bachran C, et al. 2017. Sci Rep.. 10.1038/s41598-017-17948-0. PubMed
  24. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  25. Dubrot J, et al. 2018. Life Sci Alliance. 1:e201800164. PubMed
  26. Field CS, et al. 2018. Oncoimmunology. 7:e1376154. PubMed
  27. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  28. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  29. Mayer JU, et al. 2020. Front Immunol. 11:592325. PubMed
  30. Fang C, et al. 2020. Cell Mol Immunol. . PubMed
  31. Bonnefoy F, et al. 2018. Front Immunol. 2.170833333. PubMed
  32. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  33. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  34. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  35. Lee JH, et al. 2022. iScience. 25:104166. PubMed
  36. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  37. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  38. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  39. Peng V, et al. 2020. J Biol Chem. 295:14866. PubMed
  40. Tal MC, et al. 2020. MBio. 11:00. PubMed
  41. Hitchcock JR, et al. 2020. FEBS J. 287:250. PubMed
  42. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  43. Kitai Y, et al. 2017. J Immunol. 198:1649. PubMed
  44. Sutton C, et al. 2017. Nat Commun.. 10.1038/s41467-017-02111-0. PubMed
  45. Hilligan KL, et al. 2020. Nat Commun. 11:5637. PubMed
  46. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  47. Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
  48. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
  49. Aparicio-Domingo P, et al. 2015. J Exp Med. 101084/jm20150318. PubMed
  50. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  51. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  52. Sun H, et al. 2018. J Cell Biol. 217:1453. PubMed
  53. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  54. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  55. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  56. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  57. Manni M, et al. 2018. Nat Immunol. 1.074305556. PubMed
  58. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  59. Fu H, et al. 2019. Front Immunol. 10:271. PubMed
  60. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  61. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  62. Lai JF, et al. 2020. J Allergy Clin Immunol. 146:1406. PubMed
  63. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  64. Wang Y, et al. 2021. Sci Transl Med. 13:. PubMed
  65. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  66. Molica F,et al. 2017. Sci Rep.. 10.1038/s41598-017-14130-4. PubMed
  67. Gartlan KH, et al. 2019. Blood Adv. 2.110416667. PubMed
  68. Mainini F, et al. 2018. Nucleic Acid Ther. 28:225. PubMed
  69. Enders M, et al. 2020. J Immunol. 204:87. PubMed
  70. Wei S, et al. 2019. Virulence. 0.588888889. PubMed
  71. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  72. Borges TJ, et al. 2018. Nat Commun. 9:3482. PubMed
  73. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  74. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  75. Lim CS, et al. 2020. Front Immunol. 11:1186. PubMed
  76. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  77. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  78. Nascimento DC, et al. 2017. Nat Commun. 8:14919. PubMed
  79. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  80. Majer O, et al. 2019. Nature. 575:366. PubMed
  81. Pericolini E, et al. 2008. J Leukoc Biol. 83:1286. PubMed
  82. Guilliams M, et al. 2022. Cell. 185:379. PubMed
  83. Chen HW, et al. 2021. Biomedicines. 9:. PubMed
  84. Blriot C, et al. 2021. Immunity. :. PubMed
  85. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  86. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  87. King IL, et al. 2017. Mucosal Immunol. 10:1160. PubMed
  88. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  89. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  90. Oyarce K, et al. 2018. Front Immunol. 9:112. PubMed
  91. Rebouças A, et al. 2021. Microorganisms. 9:. PubMed
  92. Rigo MM, et al. 2020. FEBS J. :. PubMed
  93. Li J, et al. 2021. Front Immunol. 12:710406. PubMed
  94. Cepeda JR, et al. 2020. MAbs. 12:1836714. PubMed
  95. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  96. Zhang Z, et al. 2018. Nat Med. 24:617. PubMed
  97. Parigi SM, et al. 2018. Sci Rep. 0.440277778. PubMed
  98. Hoffmann FM, et al. 2018. Front Immunol. 9:1046. PubMed
  99. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  100. Wikstrom M, et al. 2006. J Immunol. 177:913. PubMed
  101. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  102. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  103. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  104. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  105. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  106. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  107. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  108. Keerthivasan S, et al. 2021. Immunity. 54(7):1511-1526.e8. PubMed
  109. Hammer A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01922. PubMed
  110. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  111. von Roemeling CA, et al. 2020. Nat Commun. 11:1508. PubMed
  112. Cá B, et al. 2019. Front Microbiol. 1.876388889. PubMed
  113. Eisenach P, et al. 2010. J Cell Sci. 123:4182. PubMed
  114. Van Der Zande HJP, et al. 2021. FASEB J. 35:e21331. PubMed
  115. García G, et al. 2020. Am J Pathol. 844:190. PubMed
  116. Leppin K, et al. 2014. Invest Ophthalmol Vis Sci . 55:3603. PubMed
  117. Benson M, et al. 2007. J Exp Med. 204:1765. PubMed
  118. Simmons S et al. 2019. Elife. 8 pii: e41239. PubMed
  119. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  120. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  121. Goltsev Y et al. 2018. Cell. 174(4):968-981 . PubMed
  122. Satoh–Takayama N, et al. 2020. Immunity. 52(4):635-649. PubMed
  123. Chen B, et al. 2021. Cell. 184:6262. PubMed
  124. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  125. Danne C et al. 2017. Cell host & microbe. 22(6):733-745 . PubMed
  126. Song M, et al. 2020. Nat Commun. 11:6298. PubMed
  127. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  128. Hung LY, et al. 2019. J Immunol. 203:511. PubMed
  129. Rios–Doria J, et al. 2017. Cancer Res. 77:2686. PubMed
  130. Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
  131. Khameneh HJ, et al. 2017. J Immunol. 198:196. PubMed
  132. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  133. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  134. Fritz Y, et al. 2017. J Invest Dermatol. 137:696. PubMed
  135. Ito Y, et al. 2018. J Exp Med. 215:2617. PubMed
RRID
AB_313770 (BioLegend Cat. No. 117301)
AB_313771 (BioLegend Cat. No. 117302)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account